The MiP Consortium is a global research initiative of 47 research institutions, led by the Liverpool School of Tropical Medicine, undertaking a five year programme of research (2007-2012) to evaluate new and improved existing interventions for the prevention and treatment of malaria in pregnancy, which places up to 50 million women at risk every year.
Ten major projects direct research in four key areas of malaria in pregnancy: burden assessment, prevention, treatment and how best to scale up existing strategies and interventions. Over the next five years, expert institutions from all over the world are involved in conducting seven multicentre trials in Africa, Asia and Latin America to identify new drugs for the treatment and prevention of malaria in pregnancy to provide the evidence needed to improve the control of malaria in pregnancy. The MiP Consortium is supported by the Bill & Melinda Gates Foundation, the European and Developing Countries Clinical Trials Partnership (EDCTP) and the European Union. The Secretariat is based at the Liverpool School of Tropical Medicine.
